Form 4: Director Sells SERA Stock Under 10b5-1 Plan
Insider Transaction Report
Director Sandra AJ Lawrence reported a sale of 1,560 shares of Class A Common Stock in SERA Prognostics, Inc. under a pre-established 10b5-1 trading plan.
Summary
- Sandra AJ Lawrence, a Director at SERA Prognostics, Inc., has reported a transaction involving the sale of 1,560 shares of Class A Common Stock.
- The sale occurred on June 8, 2026, and was executed under a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2025.
- The shares were sold at a weighted average price of $2.15, with individual transactions ranging from $2.10 to $2.23.
- Following this transaction, Lawrence beneficially owns 16,473 shares of Class A Common Stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. While it reports a stock sale by a director, the transaction was conducted under a pre-arranged 10b5-1 plan, mitigating concerns about opportunistic insider trading.
Negatives
- Director sale of company stock, which can sometimes be perceived negatively by the market, although executed under a pre-planned 10b5-1 strategy.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, as it solely reports a past transaction.
Industry Context
StockSavvy.ai notes that insider sales, particularly those under a 10b5-1 plan, are common and often reflect pre-scheduled liquidity or diversification strategies rather than a negative view of the company's prospects. However, the market often scrutinizes such sales for any potential implications.
Stakeholder Impact
- Shareholders: May interpret the sale as a signal, though the 10b5-1 plan suggests it's pre-planned and not necessarily a reflection of negative company outlook.
Key Dates
| Date | Description |
|---|---|
| 06/10/2025 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 06/08/2026 | Transaction date for the sale of Class A Common Stock. |
| 06/09/2026 | Date the Form 4 was signed by the Reporting Person's attorney-in-fact. |
Keywords
SERA Prognostics, Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Director Transaction, Class A Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.